Monica Bellei

4.9k total citations · 1 hit paper
43 papers, 1.6k citations indexed

About

Monica Bellei is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Monica Bellei has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 8 papers in Immunology. Recurrent topics in Monica Bellei's work include Lymphoma Diagnosis and Treatment (30 papers), Viral-associated cancers and disorders (12 papers) and T-cell and Retrovirus Studies (8 papers). Monica Bellei is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Viral-associated cancers and disorders (12 papers) and T-cell and Retrovirus Studies (8 papers). Monica Bellei collaborates with scholars based in Italy, United States and United Kingdom. Monica Bellei's co-authors include Massimo Federico, Stefano Luminari, Stefano Pileri, Luigi Marcheselli, Barbara Pro, Philippe Solal‐Céligny, Francesco Merli, Peter McLaughlin, Maurizio Martelli and Umberto Vitolo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Monica Bellei

43 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

2009 506 citations Massimo Federico, Monica Bellei et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Bellei Italy	20	1.3k	867	314	270	265	43	1.6k
Gamal-Andre Banat Germany	10	890 0.7×	726 0.8×	534 1.7×	189 0.7×	140 0.5×	12	1.4k
M Shiota Japan	22	1.2k 0.9×	782 0.9×	324 1.0×	428 1.6×	314 1.2×	32	1.9k
Jae‐Yong Kwak South Korea	21	468 0.4×	398 0.5×	263 0.8×	225 0.8×	134 0.5×	115	1.3k
F. Calabresi Italy	21	191 0.1×	910 1.0×	76 0.2×	224 0.8×	51 0.2×	52	1.5k
Zihao Yu China	19	763 0.6×	777 0.9×	42 0.1×	285 1.1×	131 0.5×	67	1.3k
Miaoxia He China	16	299 0.2×	311 0.4×	76 0.2×	152 0.6×	74 0.3×	52	800
Hector Cohen Israel	18	464 0.4×	538 0.6×	33 0.1×	101 0.4×	32 0.1×	63	1.2k
M E van der Burg Netherlands	14	201 0.2×	635 0.7×	36 0.1×	48 0.2×	47 0.2×	18	1.4k
Ji‐Youn Sung South Korea	21	195 0.1×	478 0.6×	29 0.1×	170 0.6×	34 0.1×	90	1.4k
Eun Yoon Cho South Korea	19	193 0.1×	549 0.6×	51 0.2×	90 0.3×	22 0.1×	50	1.6k

Countries citing papers authored by Monica Bellei

Since Specialization

Citations

This map shows the geographic impact of Monica Bellei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Bellei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Bellei more than expected).

Fields of papers citing papers by Monica Bellei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Bellei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Bellei. The network helps show where Monica Bellei may publish in the future.

Co-authorship network of co-authors of Monica Bellei

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Bellei. A scholar is included among the top collaborators of Monica Bellei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Bellei. Monica Bellei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foss, Francine M., Steven M. Horwitz, Monica Civallero, et al.. (2019). Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas. American Journal of Hematology. 95(2). 151–155. 38 indexed citations

Bellei, Monica, Francine M. Foss, Andrei R. Shustov, et al.. (2018). The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project. Haematologica. 103(7). 1191–1197. 88 indexed citations

Ceriani, Luca, Lisa Milan, Maurizio Martelli, et al.. (2018). Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. Blood. 132(2). 179–186. 72 indexed citations

Foss, Francine M., Steven M. Horwitz, Monica Bellei, et al.. (2017). Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project. Blood. 130. 1512–1512. 3 indexed citations

Eichenauer, Dennis A., Ingrid Becker, Ina Monsef, et al.. (2017). Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials. Haematologica. 102(10). 1748–1757. 29 indexed citations

Zallio, Francesco, Stefania Tamiazzo, Chiara Monagheddu, et al.. (2016). Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 172(6). 879–888. 19 indexed citations

Bellei, Monica, Elena Sabattini, Emanuela Pesce, et al.. (2016). Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study. Hematological Oncology. 35(4). 630–636. 13 indexed citations

Federico, Massimo, Monica Bellei, Stefano Luminari, et al.. (2015). CD30+ expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project.. Journal of Clinical Oncology. 33(15_suppl). 8552–8552. 6 indexed citations

Bellei, Monica, Chadi Nabhan, Emanuela Anna Pesce, et al.. (2015). The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project. Current Hematologic Malignancy Reports. 10(4). 448–455. 9 indexed citations

10.

Solal‐Céligny, Philippe, Monica Bellei, Luigi Marcheselli, et al.. (2012). Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database. Journal of Clinical Oncology. 30(31). 3848–3853. 88 indexed citations

11.

Mian, Michael, Gianluca Gaïdano, Annarita Conconi, et al.. (2011). High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. Leukemia & lymphoma. 52(5). 823–832. 19 indexed citations

12.

Federico, Massimo, Stefano Molica, Monica Bellei, & Stefano Luminari. (2009). Prognostic factors in low-grade non-Hodgkin lymphomas. Current Hematologic Malignancy Reports. 4(4). 202–210. 10 indexed citations

13.

Luminari, Stefano, Marina Cesaretti, Ivan Rashid, et al.. (2007). Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy. Hematological Oncology. 25(4). 189–197. 43 indexed citations

14.

Federico, Massimo, Cesare Guglielmi, Stefano Luminari, et al.. (2007). Prognostic relevance of serum 2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Haematologica. 92(11). 1482–1488. 33 indexed citations

15.

Lardy, Henry A., et al.. (1995). Induction of Thermogenic Enzymes by DHEA and Its Metabolites. Annals of the New York Academy of Sciences. 774(1). 171–179. 24 indexed citations

16.

Kneer, Nancy, et al.. (1993). Comparative studies of effects of dehydroepiandrosterone on rat and chicken liver. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 105(3-4). 643–647. 5 indexed citations

17.

Bellei, Monica, et al.. (1992). Changes in Liver Structure and Function after Short-Term and Long-Term Treatment of Rats with Dehydroepiandrosterone. Journal of Nutrition. 122(4). 967–976. 32 indexed citations

18.

Bellei, Monica, et al.. (1992). Interaction of cartinine with mitochondrial cardiolipin. Biochimica et Biophysica Acta (BBA) - General Subjects. 1117(1). 33–36. 26 indexed citations

19.

Mokhova, E. N., E. Arrigoni‐Martelli, Monica Bellei, et al.. (1991). The protecting effect of L‐carnitine on Ca²⁺‐loaded rat liver mitochondria. FEBS Letters. 289(2). 187–189. 3 indexed citations

20.

Iannone, Anna, et al.. (1988). Effects of single or multiple doses of L-carnitine on liver energetic metabolism of rats forced to run.. PubMed. 28(3). 298–303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact